Weekly CEO Buys Highlight
- By Joy Hu
According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Energy Transfer CEO bought shares
Energy Transfer LP (ET) CEO Kelcy L. Warren bought 1 million shares on Nov. 19 at a price of $14.93. The price of the stock has decreased by 4.69% since.
Energy Transfer is a limited partnership company. Through its subsidiaries, the company owns and operates natural gas gathering systems, natural gas intrastate pipeline systems and gas processing plants. The company has a market cap of $37.24 billion. Its shares traded at $14.23 with a price-earnings ratio of 12.84 as of Nov. 23.
Warning! GuruFocus has detected 4 Warning Signs with ET. Click here to check it out.
The intrinsic value of ET
Net income for the third quarter of 2018 was $371 million, an increase of $119 million compared to the three months ended Sept. 30, 2017.
Warren bought 2 million shares on Nov. 13 at a price of $15.55. The price of the stock has decreased by 8.49% since.
Director Ray C. Davis bought 316,000 shares on Nov. 12 at a price of $15.8. The price of the stock has decreased by 9.94% since.
American Assets Trust CEO bought 29,263 shares
American Assets Trust Inc. (AAT) Chairman, CEO, President and 10% Owner Ernest S. Rady bought 29,263 shares during the past week at an average price of $39.53.
American Assets Trust is a self-administered real estate investment trust based in the United States. The company mainly invests in, operates, and develops retail, office, residential and mixed-use properties in California, Oregon and Hawaii. The company has a market cap of $2.54 billion. Its shares traded at $39.42 with a price-earnings ratio of 92.10 as of Nov. 23.
Net income for the third quarter of 2018 was $10.4 million compared to net income of $9.1 million for the three months ended Sept. 30, 2017.
Rady bought 21,608 shares on Nov. 12 at a price of $39.22; 33,967 shares on Nov. 15 at a price of $38.95; 19,627 shares on Nov. 19 at a price of $39.42; and 9,636 shares on Nov. 23 at a price of $39.75. The price of the stock has decreased by 0.83% since.
Kellogg CEO bought 17,825 shares
Kellogg Co. (NYSE:K) Chairman, President, CEO/Trustee and 10% Owner Steven A. Cahillane bought 17,825 shares on Nov. 19 at a price of $61.63. The price of the stock has increased by 0.18% since.
Kellogg is engaged in the manufacturing and marketing of ready-to-eat cereal and convenience foods. Its products include cereal, cookies, crackers and other packaged foods. The company has a market cap of $21.43 billion. Its shares traded at $61.74 with a price-earnings ratio of 12.21 as of Nov. 23.
Net income for the third quarter of 2018 was $380 million compared to $288 for the prior-year period.
Chief Financial Officer Fareed A. Khan bought 8,190 shares on Nov. 11 at a price of $62.14. The price of the stock has decreased by 0.64% since.
10% Owner W. K. Kellogg Foundation Trust sold 180,000 shares on Nov. 20 at a price of $62.24. The price of the stock has decreased by 0.8% since.
ASGN CEO bought 15,000 shares
ASGN Inc. (ASGN) CEO Peter T. Dameris bought 15,000 shares on Nov. 20 at a price of $65.92. The price of the stock has increased by 2.93% since.
ASGN, formerly On Assignment Inc., provides skilled and professionals in the growing life sciences, health care and technology sectors. The company's operating business segments are Apex and Oxford. The company has a market cap of $3.56 billion. Its shares traded at $67.85 with a price-earnings ratio of 20.07 as of Nov. 23.
Net income for the third quarter of 2018 was $49.2 million compared to $34.9 million for the comparable prior-year period.
President of ECS George H. Wilson bought 3,700 shares on Nov. 14 at a price of $66.76. The price of the stock has increased by 1.63% since.
Director Brian J. Callaghan bought 15,000 shares on Nov. 5 at a price of $68.03. The price of the stock has decreased by 0.26% since.
Board Adviser Joseph Wendell Dyer bought 250 shares on Oct. 29 at a price of $66.77. The price of the stock has increased by 1.62% since.
Madrigal Pharmaceuticals CEO bought 8,000 Shares
Madrigal Pharmaceuticals Inc. (MDGL) CEO Paul A. Friedman bought 8,000 shares during the past week at an average price of $120.94.
Madrigal Pharmaceuticals is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The company has a market cap of $1.75 billion. Its shares traded at $113.38 as of Nov. 23.
Net loss for the third quarter of 2018 was $8.51 million compared to $8.36 million for the prior-year period.
Friedman bought 4,000 shares on Nov. 19 at a price of $124 and 4,000 shares on Nov. 20 at a price of $117.88. The price of the stock has decreased by 3.82% since.
Director and 10% Owner Fred B. Craves bought 2,000 shares on Nov. 19 at a price of $124.69. The price of the stock has decreased by 9.07% since.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned.
This article first appeared on GuruFocus.
Warning! GuruFocus has detected 4 Warning Signs with ET. Click here to check it out.
The intrinsic value of ET
